Key Takeaway: PDUFA Date for Rilonacept (IL-1 Trap) Extended Three Months by FDA Action Date on Biologics License Application Extended to February 29, 2008
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+35%
120-day peak, hindsight
Typical move
2.6%
average across 15 past catalysts
Lead asset
VEGF Trap-Eye
Phase 1 · Diabetic Macular Edema
Full Press Release Details
PDUFA Date for Rilonacept (IL-1 Trap) Extended Three Months by FDA Action Date on Biologics License Application Extended to February 29, 2008.